Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: Ovarian Neoplasms and PGR[original query] |
---|
Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients. International journal of cancer. Journal international du cancer 2001 Nov 95 (6): 394-7. Tong D, Fabjani G, Heinze G, Obermair A, Leodolter S, Zeillinger |
Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review. American journal of epidemiology 2004 Feb 159 (4): 319-35. Modugno Francesma |
BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy. Mutation research 2005 Oct 578 (1-2): 395-405. Tommasi S, Crapolicchio A, Lacalamita R, Bruno M, Monaco A, Petroni S, Schittulli F, Longo S, Digennaro M, Calistri D, Mangia A, Paradiso Ange |
Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. Journal of the National Cancer Institute 2005 Jan 97 (1): 51-9. Pearce Celeste Leigh, Hirschhorn Joel N, Wu Anna H, Burtt Noël P, Stram Daniel O, Young Stanton, Kolonel Laurence N, Henderson Brian E, Altshuler David, Pike Malcolm |
The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast cancer research and treatment 2008 Jul 110 (1): 99-109. Li Wen-Feng, Hu Zhen, Rao Nan-Yan, Song Chuang-Gui, Zhang Bin, Cao Ming-Zhi, Su Feng-Xi, Wang Yong-Sheng, He Ping-Qing, Di Gen-Hong, Shen Kun-Wei, Wu Jiong, Lu Jin-Song, Luo Jian-Min, Liu Xiao-Yi, Zhou Jie, Wang Lei, Zhao Lin, Liu Yan-Bing, Yuan Wen-Tao, Yang Lin, Shen Zhen-Zhou, Huang Wei, Shao Zhi-Mi |
Association between genetic polymorphisms and ovarian cancer risk. Anticancer research 0 28 (5B): 3079-81. Delort Laetitia, Chalabi Nasséra, Satih Samir, Rabiau Nadège, Kwiatkowski Fabrice, Bignon Yves-Jean, Bernard-Gallon Dominique |
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. British journal of cancer 2008 Jan 98 (2): 282-8. Pearce C L, Wu A H, Gayther S A, Bale A E, , Beck P A, Beesley J, Chanock S, Cramer D W, DiCioccio R, Edwards R, Fredericksen Z S, Garcia-Closas M, Goode E L, Green A C, Hartmann L C, Hogdall E, Kjaer S K, Lissowska J, McGuire V, Modugno F, Moysich K, Ness R B, Ramus S J, Risch H A, Sellers T A, Song H, Stram D O, Terry K L, Webb P M, Whiteman D C, Whittemore A S, Zheng W, Pharoah P D P, Chenevix-Trench G, Pike M C, Schildkraut J, Berchuck A, |
Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach. Carcinogenesis 2010 Aug 31 (8): 1392-9. Lee Eunjung, Hsu Chris, Haiman Christopher A, Razavi Pedram, Horn-Ross Pamela L, Van Den Berg David, Bernstein Leslie, Le Marchand Loic, Henderson Brian E, Setiawan V Wendy, Ursin Gis |
Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Mar 35 (3): 2427-36. Liu Ting, Chen Lilan, Sun Xiangjun, Wang You, Li Shu, Yin Xia, Wang Xinran, Ding Chenhuan, Li He, Di W |
Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis. PloS one 2013 8 (1): 1. Chaudhary S, Panda AK, Mishra DR, Mishra SK |
Polymorphisms of progesterone receptor and ovarian cancer risk: a systemic review and meta-analysis. The journal of obstetrics and gynaecology research 2015 Feb 41 (2): 178-87. Liao Jing, Ding Dong, Sun Chaoyang, Weng Danhui, Meng Li, Chen Gang, Ma Di |
Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy. Journal of experimental & clinical cancer research : CR 2015 34 2. Tecza Karolina, Pamula-Pilat Jolanta, Kolosza Zofia, Radlak Natalia, Grzybowska E |
Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing. Genes, chromosomes & cancer 2018 02 57 (2): 51-60. Shibuya Yusuke, Tokunaga Hideki, Saito Sakae, Shimokawa Kazurou, Katsuoka Fumiki, Bin Li, Kojima Kaname, Nagasaki Masao, Yamamoto Masayuki, Yaegashi Nobuo, Yasuda J |
Molecular Evaluation of PROGINS Mutation in Progesterone Receptor Gene and Determination of its Frequency, Distribution Pattern and Association with Breast Cancer Susceptibility in Saudi Arabia. Endocrine, metabolic & immune disorders drug targets 2019 11 . Albalawi Ibrahim A, Mir Rashid, Abu-Duhier Fasel |
Genetic variation in progesterone receptor gene and ovarian cancer risk: A case control study. Gene 2022 Feb 820 146288. Kanabekova Perizat, Al-Awadi Amina M, Bauyrzhanova Zhansaya, Tahtouh Tania, Sarray Sameh, Almawi Wassim |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: